Pfizer ‘ready to roll’ if BioNTech COVID-19 shot is approvedPfizer now has hundreds of thousands of doses of BioNTech’s COVID-19 vaccine coming off the production line at Share XPfizer ‘ready to roll’ if BioNTech COVID-19 shot is approvedhttps://pharmaphorum.com/news/pfizer-ready-to-roll-if-biontech-covid-19-shot-is-approved/
Lilly pauses COVID-19 antibody trial after factory hits trouble with FDAEli Lilly has put a clinical trial of its COVID-19 antibody therapy on hold after FDA inspectors found Share XLilly pauses COVID-19 antibody trial after factory hits trouble with FDAhttps://pharmaphorum.com/news/lilly-pauses-covid-19-antibody-trial-after-factory-hits-trouble-with-fda/
BioNTech, Lilly shore up manufacturing capacity for their COVID-19 medsWith vaccines and drugs for COVID-19 now in late-stage development, companies are moving swiftly to lay down the Share XBioNTech, Lilly shore up manufacturing capacity for their COVID-19 medshttps://pharmaphorum.com/news/biontech-lilly-shore-up-manufacturing-capacity-for-their-covid-19-meds/
Sanofi set to spin off API business late next year – reportSanofi is to begin preparations in autumn to spin off its active ingredients business and is lining up a potential Share XSanofi set to spin off API business late next year – reporthttps://pharmaphorum.com/news/sanofi-set-to-spin-off-api-business-late-next-year-report/
Gilead working with generics firms to boost global supply of COVID-19 drugGilead has outlined plans to work with generics firms to rapidly increase production of its COVID-19 drug remdesivir to meet Share XGilead working with generics firms to boost global supply of COVID-19 drughttps://pharmaphorum.com/news/gilead-working-with-generics-firms-to-boost-global-supply-of-covid-19-drug/
Coronavirus has caused drug shortage, says FDA chiefThe FDA has announced the first drug shortage caused by the COVID-19 coronavirus outbreak, following previous warnings about Share XCoronavirus has caused drug shortage, says FDA chiefhttps://pharmaphorum.com/news/coronavirus-has-caused-drug-shortage-says-fda-chief/
COVID-19 could disrupt supplies of cheap generics, analysts warnAn extended COVID-19 coronavirus outbreak could impact on supplies of generic drugs that many health systems rely on Share XCOVID-19 could disrupt supplies of cheap generics, analysts warnhttps://pharmaphorum.com/news/covid-19-could-disrupt-supplies-of-cheap-generics-moodys/
Novartis taps Amazon know-how for ‘smart’ manufacturing, supply chainNovartis has joined forces with Amazon, drawing on the online retail giant’s technological wizardry to reduce bottlenecks and Share XNovartis taps Amazon know-how for ‘smart’ manufacturing, supply chainhttps://pharmaphorum.com/news/novartis-taps-amazons-know-how-for-smart-manufacturing-supply-chain/
Sanofi opens digital biologics manufacturing siteSanofi has opened a manufacturing facility in the US, one of the world’s first facilities using digital continuous Share XSanofi opens digital biologics manufacturing sitehttps://pharmaphorum.com/news/sanofi-opens-digital-biologics-manufacturing-site/
